BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22374776)

  • 1. [Genomic endophenotypes of attention deficit hyperactivity disorder].
    Fernández-Jaén A; Fernández-Mayoralas DM; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
    Rev Neurol; 2012 Feb; 54 Suppl 1():S81-7. PubMed ID: 22374776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of attention-deficit/hyperactivity disorder.
    Faraone SV; Perlis RH; Doyle AE; Smoller JW; Goralnick JJ; Holmgren MA; Sklar P
    Biol Psychiatry; 2005 Jun; 57(11):1313-23. PubMed ID: 15950004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate gene studies of ADHD: a meta-analytic review.
    Gizer IR; Ficks C; Waldman ID
    Hum Genet; 2009 Jul; 126(1):51-90. PubMed ID: 19506906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of attention deficit hyperactivity disorder.
    Thapar A; O'Donovan M; Owen MJ
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R275-82. PubMed ID: 16244326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4).
    Gizer IR; Waldman ID
    J Abnorm Psychol; 2012 Nov; 121(4):1011-23. PubMed ID: 22564179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in genetic studies of attention-deficit/hyperactivity disorder.
    Smith AK; Mick E; Faraone SV
    Curr Psychiatry Rep; 2009 Apr; 11(2):143-8. PubMed ID: 19302768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T
    Expert Rev Neurother; 2009 Oct; 9(10):1547-65. PubMed ID: 19831843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging?
    Plomp E; Van Engeland H; Durston S
    Neuroscience; 2009 Nov; 164(1):230-40. PubMed ID: 19619618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder.
    Sonuga-Barke EJ; Oades RD; Psychogiou L; Chen W; Franke B; Buitelaar J; Banaschewski T; Ebstein RP; Gil M; Anney R; Miranda A; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Thompson M; Asherson P; Faraone SV
    J Child Psychol Psychiatry; 2009 Sep; 50(9):1052-63. PubMed ID: 19490304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder endophenotypes.
    Doyle AE; Willcutt EG; Seidman LJ; Biederman J; Chouinard VA; Silva J; Faraone SV
    Biol Psychiatry; 2005 Jun; 57(11):1324-35. PubMed ID: 15950005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of attention deficit/hyperactivity disorder in Aymara and Rapa-Nui school children: association with dopaminergic system polymorphisms].
    Paz Lagos L; Silva C; Rothhammer P; Carrasco X; Llop E; Aboitiz F; Rothhammer F
    Rev Med Chil; 2011 May; 139(5):600-5. PubMed ID: 22051710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
    Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in genetic findings on attention deficit hyperactivity disorder.
    Thapar A; Langley K; Owen MJ; O'Donovan MC
    Psychol Med; 2007 Dec; 37(12):1681-92. PubMed ID: 17506925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging genetics in ADHD: a focus on cognitive control.
    Durston S; de Zeeuw P; Staal WG
    Neurosci Biobehav Rev; 2009 May; 33(5):674-89. PubMed ID: 18789356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls.
    Durston S; Fossella JA; Casey BJ; Hulshoff Pol HE; Galvan A; Schnack HG; Steenhuis MP; Minderaa RB; Buitelaar JK; Kahn RS; van Engeland H
    Mol Psychiatry; 2005 Jul; 10(7):678-85. PubMed ID: 15724142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.